摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-phenyl-pyrazolidin-3-one | 16860-34-7

中文名称
——
中文别名
——
英文名称
2-phenyl-pyrazolidin-3-one
英文别名
2-phenyl-3-pyrazolidinone;2-phenylpyrazolidin-3-one;2-Phenyl-pyrazolidin-3-on;1-Phenyl-pyrazolidon-(5);2-Phenyl-pyrazolidon-(3)
2-phenyl-pyrazolidin-3-one化学式
CAS
16860-34-7
化学式
C9H10N2O
mdl
MFCD11109215
分子量
162.191
InChiKey
DFJAJOBXRZEBAQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    263.1±23.0 °C(Predicted)
  • 密度:
    1.188±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:2557811a3445e55393ab14e2dfbe85cb
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and pharmacological characterisation of a conformationally restrained series of indole-2-carboxylates as in vivo potent glycine antagonists
    摘要:
    After the identification of GV150526, the indole-2-carboxylate template was further explored in order to identify novel potential anti-stroke agents. In particular, the SAR of the side chain present at the C-3 position of the indole nucleus was widely studied. In this paper, the synthesis and the pharmacological profile of a further class of conformationally restricted analogues of GV150526 as in vitro and in vivo potent glycine antagonists is reported. In particular, a pyrazolidinone derivative was identified as a potent neuroprotective agent in animal models of cerebral ischaemia. (C) 2001 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01141-7
  • 作为产物:
    描述:
    3-oxo-2-phenylpyrazolidine-1-carboxylic acid tert-butyl ester三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 1.0h, 以92%的产率得到2-phenyl-pyrazolidin-3-one
    参考文献:
    名称:
    Synthesis and pharmacological characterisation of a conformationally restrained series of indole-2-carboxylates as in vivo potent glycine antagonists
    摘要:
    After the identification of GV150526, the indole-2-carboxylate template was further explored in order to identify novel potential anti-stroke agents. In particular, the SAR of the side chain present at the C-3 position of the indole nucleus was widely studied. In this paper, the synthesis and the pharmacological profile of a further class of conformationally restricted analogues of GV150526 as in vitro and in vivo potent glycine antagonists is reported. In particular, a pyrazolidinone derivative was identified as a potent neuroprotective agent in animal models of cerebral ischaemia. (C) 2001 Elsevier Science S.A. All rights reserved.
    DOI:
    10.1016/s0014-827x(01)01141-7
点击查看最新优质反应信息

文献信息

  • Nucleophilic Substitution of Azide Acting as a Pseudo Leaving Group: One-Step Synthesis of Various Aza Heterocycles
    作者:Christelle Doebelin、Martine Schmitt、Cyril Antheaume、Jean-Jacques Bourguignon、Frédéric Bihel
    DOI:10.1021/jo401738f
    日期:2013.11.15
    The reaction of 3-azidopropanoic acid with the carbodiimide-based coupling reagent DIC leads to a six-membered-ring intermediate acting as a versatile precursor to a diverse set of aza heterocycles, including mono-, bi-, and tricyclic compounds.
    3-叠氮基丙酸与基于碳二亚胺的偶联剂DIC的反应导致六元环中间体充当多种氮杂杂环(包括单环,双环和三环化合物)的多用途前体。
  • 1-(Aryl)thiocarbamoyl-2-(aryl)-3-pyrazolidinones and their nematicidal
    申请人:FMC Corporation
    公开号:US04431659A1
    公开(公告)日:1984-02-14
    Compounds of the general formula ##STR1## their method of preparation, and their use to control nematodes in agricultural crops are disclosed and exemplified.
    本发明揭示并且举例化了一类通式为##STR1##的化合物的制备方法及其在农业作物中控制线虫的用途。
  • Anti-inflammatory 1,N-diarylpyrazol-3-amines, compositions containing them and processes for their preparation
    申请人:FISONS plc
    公开号:EP0178035A1
    公开(公告)日:1986-04-16
    There are described compounds of formula I, in which either R2 represents hydrogen, alkyl or Ar2, and R3 represents hydrogen, alkyl or alkyl substituted by Ar3; or R2 and R3 together form the chain-(CH2)m; R4 and R5, which may be the same or different, each independently represent hydrogen, halogen, Ar, alkyl, or alkyl substituted by Ar, Ar1, Ar2 and Ar, which may be the same or different each independently represent aryl or aryl substituted by one or more of halogen, hydroxy, -CN, -CORe, trihalomethyl, alkoxy, alkoxy substituted by -COR8, alkoxy substituted by -NR7R8, alkyl, alkyl substituted by -COR6, alkyl substituted by NR7R8, alkoxy substituted by Ar3, S(O)nR9, -NR7R8 or OAr3; R6 represents -OR10. -NR7R8, hydrogen or alkyl; R7 and R8, which may be the same or different, each independently represent hydrogen, alkyl, alkanoyl or Ar3; Rg represents alkyl or Ar3; R10 represents hydrogen, alkyl or Ar3; m represents an integer from 3 to 6 inclusive; n represents 0, 1 or 2; and Ar3 represents unsubstituted aryl; or a pharmaceutically acceptable derivative thereof. There are also described compositions containing the compounds and methods for their preparation. The compounds are indicated for use as pharmaceutical, e.g. anti-inflammatory, agents.
    所述化合物为式 I、 其中 R2 代表氢、烷基或 Ar2,R3 代表氢、烷基或被 Ar3 取代的烷基; 或 R2 和 R3 共同形成链-(CH2)m; R4 和 R5 可以相同或不同,各自独立地代表氢、卤素、Ar、烷基或被 Ar 取代的烷基、 Ar1、Ar2 和 Ar,可以相同或不同,各自独立地代表芳基或被以下一种或多种物质取代的芳基 卤素、羟基、-CN、-CORe、三卤甲基、烷氧基、被-COR8 取代的烷氧基、被-NR7R8 取代的烷氧基、烷基、被-COR6 取代的烷基、被 NR7R8 取代的烷基、被 Ar3、S(O)nR9、-NR7R8 或 OAr3 取代的烷氧基; R6 代表-OR10。-NR7R8、氢或烷基; R7 和 R8 可以相同或不同,各自独立地代表氢、烷基、烷酰基或 Ar3; Rg 代表烷基或 Ar3; R10 代表氢、烷基或 Ar3; m 代表 3 至 6(含 6)的整数; n 代表 0、1 或 2;以及 Ar3 代表未取代的芳基; 或其药学上可接受的衍生物。 此外,还描述了含有这些化合物的组合物及其制备方法。 这些化合物可用作药物,如抗炎剂。
  • Photographic direct positive material containing a masked benzotriazole stabilizer
    申请人:AGFA-GEVAERT naamloze vennootschap
    公开号:EP0527517A1
    公开(公告)日:1993-02-17
    A photographic direct positive material is disclosed comprising a support and one or more radiation sensitive emulsion layers containing internal latent image-forming silver halide grains characterized in that at least one of said emulsion layers further contains a masked stabilizer corresponding to general formula (I) : wherein Z represents a lower alkyl group, a nitro group or a halogen atom, n = 0 to 4, and M represents a positive counterion. Preferred compounds are 1-(2-sulphonatobenzoyl)-5-methyl-benzotriazole, 1-(2-sulphonatobenzoyl)-6-methyl-benzotriazole or a mixture of both. The masked stabilizer is preferably incorporated in the emulsion layer(s). The material preferably further contains a nucleating agent. Improved direct positive sensitometric properties and wider exposure latitude before encountering rereversal are obtained.
    本发明公开了一种照相直接正片材料,它包括一个支撑体和一个或多个辐射敏感乳剂层,乳剂层中含有内部潜影形成的卤化银颗粒,其特征在于所述乳剂层中至少有一层进一步含有与通式(I)相对应的掩蔽稳定剂: 其中 Z 代表低级烷基、硝基或卤素原子,n = 0 至 4,M 代表正反离子。 首选化合物为 1-(2-磺酸基苯甲酰基)-5-甲基苯并三唑、1-(2-磺酸基苯甲酰基)-6-甲基苯并三唑或两者的混合物。 掩蔽稳定剂最好掺入乳液层中。材料最好还含有成核剂。这样可以提高直接正感光特性,并在遇到反转之前获得更宽的曝光范围。
  • A new class of masked stabilizers in photographic materials or developing solutions
    申请人:AGFA-GEVAERT naamloze vennootschap
    公开号:EP0529152A1
    公开(公告)日:1993-03-03
    A new class of photographic masked stabilizers is disclosed showing following general chemical formula (Ia) or (Ib) :    wherein X and Y each independently represent N or CR, R being hydrogen or lower alkyl, Z represents a lower alkyl group, a nitro group, a halogen atom or hydrogen, and M represents a positive counterion, preferably an alkali cation, ammonium or substituted ammonium. The compounds are demasked by hydrolysis under alkaline conditions. They can be incorporated in a developing solution or in a photographic material, preferably in the backing layer. They show an enhanced solvability in water compared to the corresponding unmasked stabilizers. A preferred compound is 1-(2-sulphonatobenzoyl)-5-nitroindazole trimethylamine, sodium or potassium salt.
    公开了一类新型感光掩蔽稳定剂,其化学通式为 (Ia) 或 (Ib): 其中 X 和 Y 各自独立地代表 N 或 CR,R 是氢或低级烷基、 Z 代表低级烷基、硝基、卤素原子或氢,以及 M 代表正反离子,最好是碱阳离子、铵或取代铵。 这些化合物可在碱性条件下水解脱膜。它们可以加入到显影液或感光材料中,最好是加入到底层中。与相应的未掩蔽稳定剂相比,它们在水中的溶解能力更强。 首选化合物是 1-(2-磺酸基苯甲酰基)-5-硝基吲唑三甲胺钠盐或钾盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐